Cargando…
Podcast on the Management of Adverse Events Associated with Lorlatinib
SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02050-3.
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989848/ https://www.ncbi.nlm.nih.gov/pubmed/35147918 http://dx.doi.org/10.1007/s12325-022-02050-3 |
_version_ | 1784683260884811776 |
---|---|
author | Bauer, Todd M. Bertino, Erin M. |
author_facet | Bauer, Todd M. Bertino, Erin M. |
author_sort | Bauer, Todd M. |
collection | PubMed |
description | SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02050-3. |
format | Online Article Text |
id | pubmed-8989848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-89898482022-04-22 Podcast on the Management of Adverse Events Associated with Lorlatinib Bauer, Todd M. Bertino, Erin M. Adv Ther Commentary SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02050-3. Springer Healthcare 2022-02-11 2022 /pmc/articles/PMC8989848/ /pubmed/35147918 http://dx.doi.org/10.1007/s12325-022-02050-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Commentary Bauer, Todd M. Bertino, Erin M. Podcast on the Management of Adverse Events Associated with Lorlatinib |
title | Podcast on the Management of Adverse Events Associated with Lorlatinib |
title_full | Podcast on the Management of Adverse Events Associated with Lorlatinib |
title_fullStr | Podcast on the Management of Adverse Events Associated with Lorlatinib |
title_full_unstemmed | Podcast on the Management of Adverse Events Associated with Lorlatinib |
title_short | Podcast on the Management of Adverse Events Associated with Lorlatinib |
title_sort | podcast on the management of adverse events associated with lorlatinib |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989848/ https://www.ncbi.nlm.nih.gov/pubmed/35147918 http://dx.doi.org/10.1007/s12325-022-02050-3 |
work_keys_str_mv | AT bauertoddm podcastonthemanagementofadverseeventsassociatedwithlorlatinib AT bertinoerinm podcastonthemanagementofadverseeventsassociatedwithlorlatinib |